Virtual screening using covalent docking to find activators for G245S mutant p53.

Abstract excerpt

TP53 is the most mutated gene in all cancers. The mutant protein also accumulates in cells. The high frequency of p53 mutations makes the protein a promising target for anti-cancer therapy. Only a few molecules have been found, using in vitro screening, to reactivate the mutant protein. APR-246 is currently the most successful mutant p53 activator, which reactivates the transcriptional activity of p53 by...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Computer Simulation
• Share to Models, Genetic
• Share to Mutation